Valupak Vitamins Limited Filleted accounts for Companies House (small and micro)

VALUPAK VITAMINS LIMITED - Company Information

0 false false false false false false true false false true false false false false false false No description of principal activity 2020-05-01 Sage Accounts Production Advanced 2021 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 8992422 2020-05-01 2021-04-30 8992422 2021-04-30 8992422 2020-04-30 8992422 bus:Director1 2020-05-01 2021-04-30 8992422 core:ShareCapital 2021-04-30 8992422 core:ShareCapital 2020-04-30 8992422 bus:SmallEntities 2020-05-01 2021-04-30 8992422 bus:AuditExempt-NoAccountantsReport 2020-05-01 2021-04-30 8992422 bus:FullAccounts 2020-05-01 2021-04-30 8992422 bus:SmallCompaniesRegimeForAccounts 2020-05-01 2021-04-30 8992422 bus:EntityHasNeverTraded 2020-05-01 2021-04-30 8992422 bus:PrivateLimitedCompanyLtd 2020-05-01 2021-04-30

COMPANY REGISTRATION NUMBER: 8992422

Valupak Vitamins Limited

Filleted Unaudited Financial Statements

30 April 2021

Valupak Vitamins Limited

Statement of Financial Position

30 April 2021

	2021	2020
Note	£	£

Current assets

Debtors	4	1	1
		----	----
Net current assets		1	1
		----	----
Total assets less current liabilities		1	1
		----	----

Capital and reserves

Called up share capital	1	1
	----	----
Shareholders funds	1	1
	----	----

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.

The company did not trade during the current year or prior year and has not made either a profit or loss.

For the year ending 30 April 2021 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Director's responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

These financial statements were approved by the board of directors and authorised for issue on 15 September 2021 , and are signed on behalf of the board by:

Mr Z M M Abu Sheikha
Director

Company registration number: 8992422

Valupak Vitamins Limited

Notes to the Financial Statements

Year ended 30 April 2021

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Clayton Wood Close, West Park Ring Road, Leeds, LS16 6QE, West Yorkshire.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.

Income statement

The company is dormant as defined by section 1169 of the Companies Act 2006. The company received no income and incurred no expenditure during the current year or prior year and therefore no income statement is presented within these financial statements. There have been no movements in shareholders funds during the current year or prior year.

4. Debtors

	2021	2020
	£	£
Amounts owed by group undertakings and undertakings in which the company has a participating interest	1	1
	----	----

5. Related party transactions

There are no disclosable related party transactions.

6. Controlling party

In the opinion of the directors the ultimate controlling party is B R Pharmaceuticals Limited, a company registered in England and Wales.